Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr₹-64 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹280 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹280 Cr
Mar2023₹23 Cr
Mar2022₹-44 Cr
Mar2021₹-30 Cr
Mar2020₹-64 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹280 Cr
1,129.76
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr
Negative
Mar2021 ₹-30 Cr
Negative
Mar2020 ₹-64 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,920.0 Cr 0.1% 7.5% 0.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.1%

7.5%

0.1%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses